Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -879 | -908 | -646 | -259 | -1,208 |
| Depreciation Amortization | 90 | 63 | 36 | 18 | 125 |
| Accounts receivable | 119 | 124 | 83 | 93 | -119 |
| Accounts payable and accrued liabilities | 161 | 104 | 174 | 34 | -206 |
| Other Working Capital | 477 | 485 | 74 | -72 | -117 |
| Other Operating Activity | -710 | -184 | -228 | -127 | 806 |
| Operating Cash Flow | $-742 | $-316 | $-507 | $-313 | $-719 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 416 | 266 | 266 | 266 | 269 |
| Debt Repayment | -17 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -5 | -274 | -5 | -5 | 1 |
| Financing Cash Flow | $394 | $-8 | $261 | $261 | $270 |
| Beginning Cash Position | 413 | 413 | 413 | 413 | 862 |
| End Cash Position | 65 | 89 | 167 | 361 | 413 |
| Net Cash Flow | $-348 | $-324 | $-246 | $-52 | $-449 |
| Free Cash Flow | |||||
| Operating Cash Flow | -742 | -316 | -507 | -313 | -719 |
| Free Cash Flow | -742 | -316 | -507 | -313 | -719 |